Dear Bruce, page-14

First 14 Last

Share
Profile

Follow
DojiNinja

183 Posts.

34

04/03/20

13:37

Post #: 43300990
Share

Originally posted by tessastanle: ↑

Dear Bruce,

Thought I'd start a new thread on behalf of fellow QFE holders here. This is so you get a more direct feed than perhaps QFE hosted calls / meetings (which seem to coincide with share price dropping when taken place).

How are things with you lately? With sustained decline of QFE's share price in past months and now all the Coronavirus going around? "Play it safe til escrow" still looking good at this rate?

Look forward to having other holders contributing their input and feedback here. Feel free to chime in here yourself don't be shy.

To get the ball rolling, how about:
1. You stop re-hasing the "potential" around the US addressable market? We're past IPO and let's hear more about what tangible outcomes you're achieving across the 50 states, e.g. partnership / accreditation achieved with state accounting bodies (the California Society of CPAs equivalent), how they help QFE propogate member offers towards sign-ups.
2. You tell us how many firms you've set as targets for the sales team, and report on what's been achieved from now on?
3. You start putting into context, and reporting on what's actually been done and how you quantify your growth aspirations (slide 18 of Investor Presentation), i.e. "scaled benefits", "technology opportunities", "acquisitions"?

Expand

Hey @tessastanle,

I've sent your post to Richard Formoe on my linkedin and posted on my twitter feed to @quickfeeus. Hope you do not mind. I'll let you know of any outcomes. I think this is a great company with massive growth potential and that is why I've topped up again. Hold and pray is the right strategy, isn't it?

QFE Price at posting: 25.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

PL3

Patagonia looks to raise $2.15M for South American exploration and development

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

There are more pages in this discussion • 10 more messages in this thread...

First 14 Last

Add QFE (ASX) to my watchlist

(20min delay)
Last 7.1¢		Change 0.003(4.41%)		Mkt cap ! $23.55M

Open	High	Low	Value	Volume
7.0¢	7.1¢	7.0¢	$5.777K	81.38K

Buyers (Bids)

No.	Vol.	Price($)
1	189658	6.8¢

Sellers (Offers)

Price($)	Vol.	No.
7.1¢	48071	1

View Market Depth

No.	Vol.	Price($)
1	189658	0.068
1	66830	0.067
1	4832	0.066
3	220000	0.065
2	46616	0.060

Price($)	Vol.	No.
0.071	48071	1
0.073	10101	1
0.075	104081	2
0.076	19000	1
0.080	18928	2

Last trade - 16.10pm 09/07/2024 (20 minute delay)

QFE (ASX) Chart

Dear Bruce, page-14

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Dear Bruce, page-14

Top Stories

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News